RGM Capital’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-707,497
Closed -$11.5M 19
2017
Q2
$11.5M Hold
707,497
1.17% 20
2017
Q1
$12.3M Sell
707,497
-1,359,155
-66% -$22.7M 1.28% 21
2016
Q4
$34.9M Sell
2,066,652
-637,027
-24% -$10.6M 3.8% 14
2016
Q3
$47.4M Sell
2,703,679
-681,723
-20% -$11.1M 5.34% 7
2016
Q2
$48.6M Hold
3,385,402
5.85% 7
2016
Q1
$41.6M Buy
3,385,402
+49,202
+1% +$544K 5.23% 9
2015
Q4
$40.5M Buy
3,336,200
+155,144
+5% +$1.91M 5.29% 6
2015
Q3
$42M Buy
3,181,056
+189,262
+6% +$2.86M 5.6% 7
2015
Q2
$49.1M Buy
2,991,794
+395,015
+15% +$6.56M 6.93% 4
2015
Q1
$46.2M Sell
2,596,779
-108,741
-4% -$2.02M 7.67% 5
2014
Q4
$51.4M Sell
2,705,520
-741,735
-22% -$12.6M 7.83% 5
2014
Q3
$47.3M Sell
3,447,255
-19,944
-0.6% -$285K 8.25% 5
2014
Q2
$56.6M Buy
3,467,199
+63,498
+2% +$919K 9.44% 5
2014
Q1
$53.6M Sell
3,403,701
-31,904
-0.9% -$520K 9.81% 4
2013
Q4
$59M Buy
3,435,605
+5,951
+0.2% +$91.6K 10.59% 3
2013
Q3
$45.3M Buy
3,429,654
+320,594
+10% +$3.78M 10.48% 4
2013
Q2
$35.1M Buy
+3,109,060
New +$33.1M 10.4% 4

Other funds holding ANGO

RGM Capital's ANGO Position: Q3 2017 in Review

RGM Capital sold out of AngioDynamics (ANGO) in Q3 2017, closing a stake of 707,497 shares — an estimated $11.5M sold.

RGM Capital first reported a position in ANGO in Q2 2013 and held it in 17 quarters. The position peaked at $59M in Q4 2013. 168 funds tracked by Wall St. Rank hold ANGO as of Q3 2017.

  • RGM Capital reported no remaining AngioDynamics position as of Q3 2017 after selling out during the quarter.
  • RGM Capital sold 707,497 AngioDynamics shares in Q3 2017, an estimated $11.5M.
  • RGM Capital first reported a position in AngioDynamics in Q2 2013 and held it in 17 quarters.
  • RGM Capital's AngioDynamics position peaked at $59M in Q4 2013.
  • 168 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2017.

Based on RGM Capital's 13F filing for Q3 2017, filed 14 Nov 2017.